Blincyto ( Blinatumomab 38.5mcg) Drugs Supplier in India
If you have questions, about Blincyto ( Blinatumomab 38.5mcg) Injection, please email or Call Cellegen Biopharma Network on +91 -8800834419 / +91 -8383028495 / +91 -9953494942 for price list of our products..

Blincyto ( Blinatumomab 38.5mcg)

We can help you get approved medicine that isn't approved or available in your home country.. To learn more, fill out the form below.

BLINCYTO @ is a bispecific CD19-directed CD3 T-cell engager indicated forthe treatment of adultsand childrenwith:

  • B-cell precursoracute lymphoblastic leukemia (ALL)in first or second complete remission with minimal residual disease (MRD) greater than or equal to 0.1%. This indication is approved under accelerated approval based on MRDresponserate and hematological relapse-free survival. Continued approval for this indication may be contingent upon verification and description of clinical benefit in the confirmatory trials
  • Relapsed or refractory B-cell precursor acute lymphoblastic leukemia

The information provided herein is not medical advice and is not intend to replace medical advice offered by a health care provider. Please consult your health care provider for advice.

Quick Contact

Medicine access. Made simple Request Quote Now!
© 2021 Designed & Promoted by Gnext- Gnext Technologies
All Rights Reserved | Copyright 2021-2022 © CELLGEN
Trade Partners Franchise Download PDF